These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 12413819)

  • 1. Intellectual property protection of plant biotechnology inventions.
    Sechley KA; Schroeder H
    Trends Biotechnol; 2002 Nov; 20(11):456-61. PubMed ID: 12413819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intellectual property protection for plant-related inventions in Europe.
    Fleck B; Baldock C
    Nat Rev Genet; 2003 Oct; 4(10):834-8. PubMed ID: 14526379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Patent rights and biotechnological inventions].
    Lobato García-Miján M
    Rev Derecho Genoma Hum; 1998; (9):143-61. PubMed ID: 10335339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patenting for the research scientist: an update.
    Crespi RS
    Trends Biotechnol; 2004 Dec; 22(12):638-42. PubMed ID: 15542154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patenting pluripotence: the next battle for stem cell intellectual property.
    Vrtovec KT; Scott CT
    Nat Biotechnol; 2008 Apr; 26(4):393-5. PubMed ID: 18392018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intellectual property in higher life forms: the patent system and controversial technologies.
    Merges RP
    MD Law Rev; 1988; 47(4):1051-75. PubMed ID: 16514761
    [No Abstract]   [Full Text] [Related]  

  • 7. European Directive on the Legal Protection of Biotechnological Inventions: scope, status and controversies in a nutshell.
    Hakki MM
    E Law; 2004 Mar; 11(1):E4. PubMed ID: 16903025
    [No Abstract]   [Full Text] [Related]  

  • 8. Intellectual property rights related to the genetically modified glyphosate tolerant soybeans in Brazil.
    Rodrigues RL; Lage CL; Vasconcellos AG
    An Acad Bras Cienc; 2011 Jun; 83(2):719-30. PubMed ID: 21670890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Specificities of patent protection in the pharmaceutical industry: modalities and traits of intellectual property].
    Jannuzzi AH; Vasconcellos AG; de Souza CG
    Cad Saude Publica; 2008 Jun; 24(6):1205-18. PubMed ID: 18545747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Patents on life? No patent on life!].
    van Raden L
    Dtsch Tierarztl Wochenschr; 1998 Mar; 105(3):90-3. PubMed ID: 9581373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patent first, ask questions later: morality and biotechnology in patent law.
    Bagley MA
    William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patentable subject matter, TRIPS and the European Biotechnology Directive: Australia and patenting human genes.
    Palombi L
    Univ N S W Law J; 2003; 26(3):782-92. PubMed ID: 16617532
    [No Abstract]   [Full Text] [Related]  

  • 13. Towards harmonization: the European biotechnology patent directive.
    Curley D
    J Biolaw Bus; 2002; 5(3):64-8. PubMed ID: 12816122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing genetic material to protect intellectual property rights.
    Jong SC; Cypess RH
    J Ind Microbiol Biotechnol; 1998 Feb; 20(2):95-100. PubMed ID: 9611821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethico-legal issues in biomedicine patenting: a patent professional viewpoint.
    Crespi RS
    Sci Eng Ethics; 2005 Jan; 11(1):117-36. PubMed ID: 15727007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intellectual property. Plants and intellectual property: an international appraisal.
    Koo B; Nottenburg C; Pardey PG
    Science; 2004 Nov; 306(5700):1295-7. PubMed ID: 15550646
    [No Abstract]   [Full Text] [Related]  

  • 17. The prodigal son: the relationship between patent law and health care.
    Bostyn SJ
    Med Law Rev; 2003; 11(1):67-120. PubMed ID: 14606473
    [No Abstract]   [Full Text] [Related]  

  • 18. Plants genetic manipulation: an approach from intellectual property.
    Ruiz AN; Rivero LP
    Front Biosci (Elite Ed); 2013 Jan; 5(2):408-17. PubMed ID: 23276998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alienation from the Objectives of the Patent System: How to Remedy the Situation of Biotechnology Patent.
    Jiang L
    Sci Eng Ethics; 2019 Jun; 25(3):791-811. PubMed ID: 29532279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patenting the life sciences at the European Patent Office.
    Gates C
    Cold Spring Harb Perspect Med; 2014 Oct; 4(12):a020792. PubMed ID: 25342060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.